Abstract:Introduction: CXCL17 is a mucosally secreted protein, and the most recently identified human chemokine, an assignment based on protein fold prediction and chemotactic activity for leukocytes. However, these credentials have been the subject of much recent discussion and no experimental evidence has been presented regarding the definitive structure of CXCL17. In this study, we evaluated the structural and chemoattractant credentials of CXCL17 to better characterize this molecule, and gain deeper insights into its functional role as a glycosaminoglycan (GAG) binding protein. Methods: In the absence of structural information, in silico modeling techniques assessed the likelihood of CXCL17 adopting a chemokine fold. Recombinant CXCL17 was synthesized in mammalian and prokaryotic systems. Modified Boyden chamber and real-time chemotaxis assays assessed the ability of CXCL17 to promote chemotaxis of murine splenocytes, human neutrophils, and CXCR1 transfectants. The efficacy of CXCL17 binding to GAGs was quantified with solid-phase assays and bio-layer interferometry techniques. Results: All modeling efforts failed to support classification of CXCL17 as a chemokine based on its predicted conformation. Recombinant CXCL17 was observed to dimerize as a function of concentration, a characteristic of several chemokines. Contrary to a previous report, CXCL17 was not chemotactic for murine splenocytes, although it was a low-potency chemoattractant for human neutrophils at micromolar concentrations, several orders of magnitude higher than those required for CXCL8. As anticipated owing to its highly basic nature, CXCL17 bound to GAGs robustly, with key C-terminal motifs implicated in this process. While inactive via CXCR1, CXCL17 was found to inhibit CXCR1-mediated chemotaxis of transfectants to CXCL8 in a dose-dependent manner. Discussion: In summary, despite finding little evidence for chemokine-like structure and function, CXCL17 readily bound GAGs, and could modulate chemotactic responses to another chemokine in vitro. We postulate that such modulation is a consequence of superior GAG binding, and that C-terminal fragments of CXCL17 may serve as prototypic inhibitors of chemokine function.

Identification of the orphan GPR25 as a receptor of the chemokine CXCL17

ACKR5/GPR182 is a scavenger receptor for the atypical chemokine CXCL17, GPR15L and various endogenous peptides

Cryo-EM structures of orphan GPR21 signaling complexes

Structural and functional characterization of the endogenous agonist for orphan receptor GPR3

Molecular Cloning and Primary Identification of Hgpcrc:A Human Orphan G-protein-coupled Receptor

Constitutively Active BRS3 is a Genuinely Orphan GPCR in Placental Mammals

The activation mechanism and antibody binding mode for orphan GPR20

CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling

Molecular recognition of the atypical chemokine-like peptide GPR15L by its cognate receptor GPR15

Uncovering the signalling, structure and function of the 20‐HETE‐GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75

The Role and Clinical Significance of the CXCL17-CXCR8 (GPR35) Axis in Breast Cancer

Structure basis of ligand recognition and activation of GPR55

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans

The Orphan G Protein-Coupled Receptor 25 (GPR25) is Activated by Apelin and Apela in Non-Mammalian Vertebrates

A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

Dynamic Insights into the Self-Activation Pathway and Allosteric Regulation of the Orphan G-Protein-Coupled Receptor GPR52

[Subcellular Localization and Tissues Expression Profile of Hgpcrc: an Orphan G Protein-Coupled Receptor].

Orphan G-protein coupled receptor GPCR-X as a novel cancer drug target: validation and mechanistic studies

GPR39: An orphan receptor begging for ligands

Research Status of the Orphan G Protein Coupled Receptor 158 and Future Perspectives

What defines a chemokine? - The curious case of CXCL17